MedTrace Logo

Transversus Abdominis Plane (TAP) Block for Cesarean Section

NCT01015807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2017-10-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether a transversus abdominis plane (TAP) block with Clonidine added to the injectate (Clo-TAP) performed approximately 2hrs after the cesarean section (CS) will decrease the amount of postoperative hyperalgesia and ultimately reduce post-CS chronic pain.

Conditions

  • Hyperalgesia, Secondary

Interventions

DRUG

Bupivacaine Placebo

2 x 20mL 0.9% NaCl

DRUG

Clonidine Placebo

2 x 1mL 0.9% NaCl

DRUG

Bupivacaine

2 x 20mL 0.375% Bupivacaine = 150 mg Bupivacaine

DRUG

Clonidine

2 x 1ml Clonidine = 150 µg Clonidine

Sponsors & Collaborators

Principal Investigators

  • Ruth Landau, MD · University of Washington

  • Laurent Bollag, MD · University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2010-08-31
Completion
2012-08-31

Countries

  • United States
  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01015807 on ClinicalTrials.gov